MSP Recovery Shares Double After Agreeing to Term-Sheet Outlining Restructuring

Dow Jones
11 Apr

By Connor Hart

Shares of MSP Recovery soared after the company agreed to a term sheet outlining several restructuring transactions with Hazel Partners and Virage Capital Management.

The stock doubled to $2.55 in after-hours trading. Through Thursday's close, shares have lost nearly 96% of their value in the past year.

The Medicare, Medicaid, commercial and secondary-payer reimbursement company said that initiatives included in the non-binding agreement will reduce costs, release $1.2 billion in debt and provide funding.

Under the agreement, Hazel would provide up to $25 million in operational funding through a structured facility, paid in monthly batches and subject to meeting certain milestones beginning in September, with a maturity date of June 30, 2027. The firm would additionally provide MSP with up to $9.8 million of bridge funding.

Virage would agree to waive all claims and release all liens against MSP relating to an outstanding loan in exchange for 43% equity interest.

"These transactions represent a critical turning point for MSP Recovery," Chief Executive Officer John Ruiz said. "By aligning with strategic partners and securing operational funding, we believe we have established a foundation that not only addresses past challenges but positions us for long-term growth.

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

April 10, 2025 20:09 ET (00:09 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10